SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma

Tao Guo, Ran Wei, Dylan C. Dean, Francis J. Hornicek, Zhenfeng Duan

Open source

DOI
10.1042/bsr20212446
Published
2022-01
Container
Bioscience Reports
Publisher
Portland Press Ltd.
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1042/bsr20212446,
  title = {SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma},
  author = {Tao Guo and Ran Wei and Dylan C. Dean and Francis J. Hornicek and Zhenfeng Duan},
  year = {2022},
  journal = {Bioscience Reports},
  doi = {10.1042/bsr20212446},
  url = {https://doi.org/10.1042/bsr20212446}
}

RIS

TY  - JOUR
TI  - SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma
AU  - Tao Guo
AU  - Ran Wei
AU  - Dylan C. Dean
AU  - Francis J. Hornicek
AU  - Zhenfeng Duan
PY  - 2022
JO  - Bioscience Reports
DO  - 10.1042/bsr20212446
UR  - https://doi.org/10.1042/bsr20212446
ER  - 

APA

Guo, T., Wei, R., Dean, D. C., Hornicek, F. J., & Duan, Z. (2022). SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma. Bioscience Reports. https://doi.org/10.1042/bsr20212446

Source records